Literature DB >> 19387316

Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma.

Bon Seok Koo1, Eun Chang Choi, Yeo-Hoon Yoon, Dong-Hyun Kim, Eung-Hyub Kim, Young Chang Lim.   

Abstract

OBJECTIVES: To investigate the incidence and the risk factors for occult ipsilateral or contralateral central neck lymph node (LN)metastasis in patients with unilateral papillary thyroid carcinoma (PTC) and a clinically negative neck. SUMMARY BACKGROUND DATA: Elective central lymph node dissection (CLND) in patients with PTC remains controversial. There have been few prospective studies assessing accurate histopathologic information and predictive factors for the presence of metastasis to the ipsilateral or contralateral central compartment of the neck in patients with PTC and clinically negative neck nodes.
METHODS: We reviewed a prospective protocol of 111 unilateral PTC patients with clinically node-negative necks who have received total thyroidectomy and elective bilateral CLND from 2005 to 2007. The relationships between LN metastasis to the ipsilateral or contralateral central neck compartment and clinico-pathologic factors such as age, sex, size of primary tumor, perithyroidal invasion, lymphovascular invasion, and capsular invasion were analyzed.
RESULTS: Occult central neck LN metastasis was present in 54.1% (60/111). Of these patients, bilateral central LN metastases were present in 50% (30/60), unilateral ipsilateral central LN metastasis in 43.3% (26/60), and unilateral contralateral central LN metastasis in 6.7% (4/60). In the univariate analysis, the rate of ipsilateral central LN metastasis was significantly higher in male patients, high risk MACIS score, carcinoma with a maximal diameter of greater than 1 cm, and carcinoma with lymphovascular invasion (P < 0.05). The rate of contralateral central LN metastasis was significantly higher in cases of carcinoma with a maximal diameter of greater than 1 cm, lymphovascular invasion or histologically proven metastasis to the ipsilateral central LN (P < 0.05). Multivariate analysis showed that the tumor size was an independent risk factor for the presence of ipsilateral central LN metastasis, and the presence of ipsilateral central LN metastasis was the only independent predictor for the presence of contralateral central LN metastasis.
CONCLUSIONS: Unilateral PTC with a maximal diameter of greater than 1 cm is associated with a high rate of ipsilateral central neck LN metastasis. Moreover, ipsilateral central LN metastasis is a potential independent predictor of synchronous contralateral central LN metastasis. These findings suggest that contralateral as well as ipsilateral elective CLND, performed during the initial thyroid operation, may be effective in the management of patients with unilateral PTC having a maximal diameter of greater than 1 cm and ipsilateral central LN metastasis.

Entities:  

Mesh:

Year:  2009        PMID: 19387316     DOI: 10.1097/SLA.0b013e3181a40919

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  55 in total

1.  Quantification of lymph nodes in the central compartment of the neck: a cadaveric study.

Authors:  Enyinnaya Ofo; Selvam Thavaraj; Daron Cope; James Barr; Karan Kapoor; Jean-Pierre Jeannon; Richard Oakley; Claire Lock; Edward Odell; Ricard Simo
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-20       Impact factor: 2.503

2.  Prediction of ipsilateral and contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma: a retrospective study.

Authors:  Qiang Chen; Xiu-He Zou; Tao Wei; Qiu-Shi Huang; Ying-He Sun; Jing-Qiang Zhu
Journal:  Gland Surg       Date:  2015-08

Review 3.  Prophylactic central neck disection in papillary thyroid cancer: a consensus report of the European Society of Endocrine Surgeons (ESES).

Authors:  Juan J Sancho; Thomas W Jay Lennard; Ivan Paunovic; Frédéric Triponez; Antonio Sitges-Serra
Journal:  Langenbecks Arch Surg       Date:  2013-12-19       Impact factor: 3.445

4.  Level IIb lymph node metastasis in thyroid papillary carcinoma.

Authors:  Yusuf Vayisoglu; Cengiz Ozcan; Ozgur Turkmenoglu; Kemal Gorur; Murat Unal; Ahmet Dag; Koray Ocal
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-01-07       Impact factor: 2.503

Review 5.  Impact of prophylactic central neck dissection on oncologic outcomes of papillary thyroid carcinoma: a review.

Authors:  Elisabeth Mamelle; Isabelle Borget; Sophie Leboulleux; Haïtham Mirghani; Carlos Suárez; Phillip K Pellitteri; Ashok R Shaha; Marc Hamoir; K Thomas Robbins; Avi Khafif; Juan P Rodrigo; Carl E Silver; Alessandra Rinaldo; Alfio Ferlito; Dana M Hartl
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-11       Impact factor: 2.503

6.  MiR-9 and miR-21 as prognostic biomarkers for recurrence in papillary thyroid cancer.

Authors:  Adriana Sondermann; Flavia Maziero Andreghetto; Ana Carolina Bernardini Moulatlet; Elivane da Silva Victor; Marilia Germanos de Castro; Fábio Daumas Nunes; Lenine Garcia Brandão; Patricia Severino
Journal:  Clin Exp Metastasis       Date:  2015-05-26       Impact factor: 5.150

7.  Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.

Authors:  J-W Feng; X-H Yang; B-Q Wu; D-L Sun; Y Jiang; Z Qu
Journal:  Clin Transl Oncol       Date:  2019-03-16       Impact factor: 3.405

8.  A retrospective study of the risk factors and the prognosis in patients with papillary thyroid carcinoma depending on the number of lymph node metastasis.

Authors:  Zhong Ying Rui; Yang Liu; Wei Zheng; Xuan Wang; Zhao Wei Meng; Jian Tan; Ning Li; Qiang Jia
Journal:  Clin Exp Med       Date:  2021-01-01       Impact factor: 3.984

Review 9.  Surgical approach to level VI in papillary thyroid carcinoma: an overview.

Authors:  Carmela De Crea; Marco Raffaelli; Luca Sessa; Celestino Pio Lombardi; Rocco Bellantone
Journal:  Updates Surg       Date:  2017-06-13

10.  Is BRAF mutation associated with lymph node metastasis in patients with papillary thyroid cancer?

Authors:  Kathleen C Lee; Carol Li; Eric B Schneider; Yongchun Wang; Helina Somervell; Matthew Krafft; Christopher B Umbricht; Martha A Zeiger
Journal:  Surgery       Date:  2012-10-11       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.